{"chunk_id": "medquad__chunk_8487", "source": "medquad", "text": "Childhood Acute Lymphoblastic Leukemia\n\t\t\t\t\t\t                    There is no standard treatment for the treatment of refractory childhood acute lymphoblastic leukemia (ALL).    Some of the treatments being studied in clinical trials for refractory childhood ALL include:         -  Targeted therapy (blinatumomab or inotuzumab).     -  Chimeric antigen receptor (CAR) T-cell therapy.\n\t\t\t\t\t\t                \n\t\t\t\t\t\t                \n\t\t\t\t\t\t                    Relapsed Childhood Acute Lymphoblastic Leuke"}